drugset / Trial / NCT02179138

Paper Applicator Acceptability Study

NCT02179138

Phase 1/2 Withdrawn CONRAD
NaSingle-groupOpen-label

Summary

To assess the acceptability of a user-filled, paper, applicator for delivery of tenofovir (TFV) gel among women at high risk of acquiring human immunodeficiency virus (HIV) in rural KwaZulu-Natal, South Africa.

Timeline

Start
Primary completion
2015-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Tenofovir Small molecule 1 %

Indications

No indication recorded.